Key Takeaways
- • CVC Capital Partners is acquiring International Flavors & Fragrances' (IFF) food ingredients division for approximately $4.3 billion, with closing expected by the end of June 2027, generating net cash proceeds of $3.8 billion for IFF.
- • IFF will retain a 10% minority stake in the divested business, which manufactures sweeteners, emulsifiers, and specialty ingredients for industrial food production and reported $802 million in Q4 2025 net sales (down 4% year-over-year before returning to 3% growth in Q1 2026).
- • The transaction represents IFF's continued portfolio rationalization following a strategic review, with the company now focused on core taste, scent, and health and biosciences segments after divesting 13 non-core assets generating approximately $10 billion in gross proceeds.
- • The deal exemplifies a broader private equity trend targeting large corporate carve-outs as macroeconomic headwinds and elevated interest rates challenge traditional leveraged buyout models, with recent comparable transactions including Advent International's Reckitt cleaning products acquisition and Clayton, Dubilier & Rice's Sanofi consumer health purchase.
Summary
CVC Capital Partners has agreed to acquire the food ingredients division of International Flavors & Fragrances in a $4.3 billion transaction, marking another significant sponsor-led carve-out as private equity firms increasingly target non-core corporate assets. The business, which produces sweeteners, emulsifiers, and specialty ingredients for industrial food applications, will generate approximately $3.8 billion in net cash proceeds for IFF upon completion, currently targeted for the end of June 2027. IFF will maintain a 10% minority stake in the division post-closing, signaling continued alignment with the business's trajectory.
The sale furthers IFF's strategic portfolio reshaping, initiated through a comprehensive review last year as the company refocuses on its core taste, scent, and health and biosciences operations. The food ingredients segment had faced headwinds from weaker demand across alternative proteins, emulsifiers, and sweeteners markets. Financial performance reflected this pressure, with the division reporting $802 million in net sales during Q4 2025, representing a 4% year-over-year decline, though the business stabilized with 3% growth in Q1 2026. To date, IFF has successfully divested 13 non-core assets, generating close to $10 billion in aggregate gross proceeds, demonstrating the company's disciplined capital allocation approach.
The transaction underscores a pronounced shift in private equity dealmaking dynamics. Sponsor-led carve-outs have accelerated as traditional leveraged buyout structures face pressure from persistently elevated interest rates and macroeconomic uncertainty. CVC's food ingredients acquisition joins a cohort of comparable large-scale carve-outs, including Advent International's acquisition of Reckitt Benckiser's cleaning products division, Clayton, Dubilier & Rice's purchase of Sanofi's consumer health business, and CVC's own earlier agreement to acquire DSM-Firmenich's animal nutrition division. These transactions reflect private equity's strategic pivot toward acquiring mature, cash-generative divisions from diversified corporations—often more defensive positioning than traditional leveraged buyouts.
The sale furthers IFF's strategic portfolio reshaping, initiated through a comprehensive review last year as the company refocuses on its core taste, scent, and health and biosciences operations. The food ingredients segment had faced headwinds from weaker demand across alternative proteins, emulsifiers, and sweeteners markets. Financial performance reflected this pressure, with the division reporting $802 million in net sales during Q4 2025, representing a 4% year-over-year decline, though the business stabilized with 3% growth in Q1 2026. To date, IFF has successfully divested 13 non-core assets, generating close to $10 billion in aggregate gross proceeds, demonstrating the company's disciplined capital allocation approach.
The transaction underscores a pronounced shift in private equity dealmaking dynamics. Sponsor-led carve-outs have accelerated as traditional leveraged buyout structures face pressure from persistently elevated interest rates and macroeconomic uncertainty. CVC's food ingredients acquisition joins a cohort of comparable large-scale carve-outs, including Advent International's acquisition of Reckitt Benckiser's cleaning products division, Clayton, Dubilier & Rice's purchase of Sanofi's consumer health business, and CVC's own earlier agreement to acquire DSM-Firmenich's animal nutrition division. These transactions reflect private equity's strategic pivot toward acquiring mature, cash-generative divisions from diversified corporations—often more defensive positioning than traditional leveraged buyouts.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.